Crossmark

Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreatic cancer based on CT, 18F-FDG PET/CT, DNA mutation, and CA199

Crossref DOI link: https://doi.org/10.1186/s12935-025-03639-8

Published Online: 2025-01-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qi, Liang

Li, Xiang

Ni, Jiayao

Du, Yali

Gu, Qing

Liu, Baorui

He, Jian

Du, Juan
License Information

Text and Data Mining valid from 2025-01-19

Version of Record valid from 2025-01-19
More Information

Article History

Received: 22 July 2024

Accepted: 7 January 2025

First Online: 19 January 2025

Declarations

:

: Approval from the local institutional ethics review board was obtained, and the requirement for written informed consent was waived. All procedures involving human participants were conducted in accordance with the principles outlined in the 1975 Helsinki Declaration and its later amendments.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below